Work

Carcinoma of unknown primary: Molecular tumor board‐based therapy

Year: 2022

Type: article

Abstract: CA: A Cancer Journal for Clinicians publishes information about the prevention, early detection, and treatment of cancer, as well as nutrition, palliative care, survivorship, and additional topics of interest related to cancer care.

Source: CA A Cancer Journal for Clinicians

DOI: 10.3322/caac.21748

Authors: Aditya V. Shreenivas, Shumei Kato, Jingjing Hu, Catherine Skefos, Jason Sicklick, Razelle Kurzrock

Institutions: Medical College of Wisconsin, Medical College of Wisconsin Cancer Center, University of California San Diego, Moores Cancer Center, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Cancer Diagnosis and Treatment

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $4,330

Funders: Amgen, Pfizer, F. Hoffmann-La Roche, Medpace, Natera, Grifols, Genentech, Foundation Medicine, National Cancer Institute

Award: Targeting Drug-Resistant Cancer Stem Cell Niches of Gastrointestinal Stromal Tumor

OpenAlex ID: W4293049422

FWCI: 0.271

Cites: 55

Cited by: 4

Related to: 10